Hereditary Angioedema: Causes, Symptoms, and Treatment Options

Introduction

Hereditary angioedema (HAE) is a rare but serious genetic disorder that leads to recurrent swelling in various parts of the body, including the skin, gastrointestinal tract, and airways. First identified in the 19th century, HAE is now recognized as a condition that can significantly affect quality of life if not properly managed. Swelling episodes can be painful and, in some cases, life-threatening, particularly when they involve the throat or airways. This article provides a comprehensive overview of HAE, covering its risk factors, symptoms, diagnostic tests, treatment options, and home care strategies. Understanding these aspects helps patients manage their condition and work closely with healthcare providers to prevent complications.

What is Hereditary Angioedema?

Hereditary angioedema (HAE) is a genetic disorder characterized by recurrent episodes of swelling. Risk factors, symptoms, diagnostic tests, medications, procedures, and home care strategies all play a role in its management.

Description of Hereditary Angioedema

Hereditary angioedema (HAE) is a rare genetic condition that impairs the body’s ability to regulate swelling. It is caused by a deficiency or dysfunction of the C1 inhibitor protein, which normally helps control inflammation. Without enough functional C1 inhibitor, the body experiences uncontrolled swelling, particularly in the skin, gastrointestinal tract, and airways. These episodes can last several days and may occur without warning.

The progression of HAE varies from person to person. Some individuals experience frequent attacks, while others have only occasional episodes. The severity of swelling also differs, ranging from mild discomfort to severe pain or life-threatening airway obstruction.

HAE is rare, affecting approximately 1 in 50,000 people worldwide. It is inherited in an autosomal dominant pattern, meaning there is a 50% chance of passing it to children if one parent has the condition. While HAE can affect individuals of all ages, symptoms often begin in childhood or adolescence and may worsen over time if not properly managed.

Risk Factors for Developing Hereditary Angioedema

Lifestyle Risk Factors

Although hereditary angioedema is primarily genetic, certain lifestyle factors can trigger or worsen swelling episodes. Stress is a common trigger, as both emotional and physical stress can increase inflammation. Trauma or injury, such as surgery or dental work, may provoke an attack by causing localized swelling. Hormonal changes, such as those occurring during pregnancy or menstruation, can also increase the likelihood of an episode. Additionally, certain medications, particularly ACE inhibitors used to treat high blood pressure, have been known to trigger HAE attacks in some individuals.

Medical Risk Factors

A family history of HAE significantly increases the risk of developing the condition. However, the severity and frequency of symptoms can vary even among family members. Individuals with other inflammatory or autoimmune disorders may experience more frequent or severe HAE attacks. For example, conditions like lupus or rheumatoid arthritis can exacerbate HAE-related swelling. Infections or illnesses that cause inflammation may also trigger an attack.

Genetic and Age-Related Risk Factors

HAE is inherited and caused by a mutation in the gene responsible for producing C1 inhibitor, a protein that regulates swelling and inflammation. If one parent has HAE, there is a 50% chance their child will inherit the condition. However, not everyone who inherits the gene mutation will experience symptoms immediately. HAE symptoms often begin in childhood or adolescence but can appear later in life. In some cases, symptoms may worsen with age, especially if the condition is not properly managed.

Clinical Manifestations of Hereditary Angioedema

Abdominal Pain

Abdominal pain affects 70-80% of HAE patients and is caused by swelling in the intestinal walls, leading to cramping and discomfort. The pain can be severe and is sometimes mistaken for other gastrointestinal conditions like appendicitis or irritable bowel syndrome. It may be accompanied by nausea, vomiting, or diarrhea. Abdominal attacks can occur at any stage of the disease and may be more frequent in those with a family history of gastrointestinal involvement.

Swelling of the Face

Facial swelling occurs in 30-50% of HAE patients due to fluid accumulation in the tissues beneath the skin. It can affect the eyes, lips, and cheeks, causing discomfort or disfigurement. Triggers include stress, trauma, or dental procedures. While not life-threatening, facial swelling can interfere with daily activities such as eating or speaking.

Swelling of the Extremities

Swelling of the arms, legs, hands, or feet affects 50-60% of HAE patients. This swelling is caused by fluid leakage from blood vessels into surrounding tissues, leading to puffiness and discomfort. It may be localized or affect multiple extremities at once. Physical exertion, prolonged standing, or minor injuries can trigger extremity swelling, which, while not dangerous, can be painful and limit mobility.

Swelling of the Airway

Airway swelling is one of the most serious complications of HAE, affecting 10-20% of patients. It can involve the throat, tongue, or larynx, leading to difficulty breathing or swallowing. In severe cases, airway swelling can cause life-threatening obstruction, requiring emergency medical intervention. Patients with a history of airway attacks are often advised to carry emergency medications, such as injectable C1 inhibitors, to prevent or treat swelling before it becomes critical.

Skin Rash

About 10-15% of HAE patients may experience a non-itchy skin rash called erythema marginatum. This rash appears as red, ring-shaped patches and may precede or accompany an angioedema attack. While not harmful, it can signal an impending swelling episode. Recognizing this symptom is important for seeking timely treatment.

Nausea, Vomiting, and Diarrhea

Nausea, vomiting, and diarrhea occur in 40-60% of HAE patients during abdominal attacks. These symptoms result from swelling in the gastrointestinal tract, disrupting normal digestion and bowel function. Severe cases can lead to dehydration if not managed properly. Patients experiencing these symptoms should seek medical advice to ensure proper hydration and symptom control.

Fatigue

Fatigue affects 30-40% of HAE patients and may occur during or after an angioedema attack as the body recovers from the physical stress of swelling. Fatigue can also be a side effect of medications used to treat or prevent attacks. Patients with persistent fatigue should discuss their symptoms with their healthcare provider to rule out other causes and adjust treatment if necessary.

Headache

Headaches are reported in 20-30% of HAE patients, particularly during or after an attack. The cause of headaches in HAE is not well understood, but they may be related to changes in blood flow or pressure due to swelling. Headaches can range from mild to severe and may be accompanied by nausea or light sensitivity. Patients with frequent or severe headaches should consult their healthcare provider for appropriate management.

Diagnostic Evaluation of Hereditary Angioedema

Diagnosing hereditary angioedema (HAE) involves clinical evaluation, laboratory tests, and genetic analysis. Diagnosis is typically based on symptoms, family history, and specific blood tests that measure the levels and function of proteins involved in the immune system. HAE is often suspected in patients with recurrent swelling episodes without an allergic trigger. Once suspected, diagnostic tests confirm the diagnosis and determine the specific type of HAE, helping differentiate it from other forms of angioedema, such as those caused by allergies or medications.

C4 Complement Level

The C4 complement level test measures the amount of C4 protein in the blood, which is part of the complement system that helps the immune system fight infections. In HAE, C4 levels are typically low, even between attacks. This test is crucial because low C4 levels are a hallmark of HAE and help differentiate it from other types of angioedema, such as allergic angioedema, where C4 levels are usually normal.

Results that Indicate Hereditary Angioedema

In HAE patients, C4 levels are usually below the normal range, often less than 50% of the expected value. A low C4 level, combined with a history of recurrent swelling, strongly suggests HAE. If C4 levels are normal, it may indicate the patient does not have HAE, but further testing is often required, as C4 levels can occasionally be normal during attack-free periods.

C1 Inhibitor Level

The C1 inhibitor level test measures the amount of C1 inhibitor protein in the blood. C1 inhibitor regulates the complement system and prevents excessive swelling. In HAE, there are two main types: Type I, where C1 inhibitor levels are low, and Type II, where C1 inhibitor levels are normal but dysfunctional. This test helps determine whether a patient has Type I or Type II HAE.

Results that Indicate Hereditary Angioedema

In Type I HAE, C1 inhibitor levels are typically less than 50% of the normal range. In Type II HAE, C1 inhibitor levels may be normal or slightly reduced, but the protein does not function properly. If C1 inhibitor levels are normal and functioning correctly, it is unlikely the patient has HAE, and other causes of angioedema should be considered.

C1 Inhibitor Function Test

The C1 inhibitor function test assesses how well the C1 inhibitor protein works. Even if C1 inhibitor levels are normal, the protein may not function properly, as seen in Type II HAE. This test is crucial for distinguishing between Type I and Type II HAE and confirming the diagnosis in patients with borderline C1 inhibitor levels.

Results that Indicate Hereditary Angioedema

In Type II HAE, C1 inhibitor function is typically less than 50% of the normal range, even if protein levels are normal. If C1 inhibitor function is normal, it suggests the patient does not have HAE, and other diagnostic avenues should be explored. If function is impaired, further testing, such as genetic analysis, may be recommended to confirm the diagnosis.

Genetic Testing

Genetic testing identifies mutations in the SERPING1 gene, which is responsible for producing C1 inhibitor. This test is particularly useful for confirming HAE in patients with borderline or inconclusive results from other tests. It can also help identify family members at risk for HAE, even if they have not yet developed symptoms.

Results that Indicate Hereditary Angioedema

A positive result for a mutation in the SERPING1 gene confirms HAE. If no mutation is found, it is less likely the patient has HAE, but other forms of angioedema, such as acquired angioedema, should be considered. Genetic counseling may be recommended to discuss the implications of test results and potential risks for future generations.

Serum Tryptase Level

Serum tryptase is a marker of mast cell activation, which is involved in allergic reactions. Measuring serum tryptase levels helps differentiate HAE from allergic angioedema, as tryptase levels are typically elevated in allergic reactions but normal in HAE. This test is useful when the cause of angioedema is unclear, and an allergic component needs to be ruled out.

Results that Indicate Hereditary Angioedema

In HAE patients, serum tryptase levels are usually normal. Elevated tryptase levels suggest the swelling may be due to an allergic reaction or another condition involving mast cell activation. If tryptase levels are normal, it supports the diagnosis of HAE, but further testing is required to confirm the diagnosis.

What if All Tests are Negative but Symptoms Persist?

If all diagnostic tests are negative but swelling symptoms persist, it is important to continue working with your healthcare provider to explore other potential causes of angioedema. Other forms, such as acquired or idiopathic angioedema, may need to be considered. Your healthcare provider may recommend additional testing, such as imaging studies or allergy testing, to rule out other conditions. Keeping a detailed record of symptoms and potential triggers can help guide further evaluation and treatment.

Treatment Options for Hereditary Angioedema

Medications for Hereditary Angioedema

C1 Inhibitor Concentrate

C1 inhibitor concentrate replaces the deficient or malfunctioning C1 inhibitor protein in hereditary angioedema (HAE) patients. This protein plays a key role in regulating inflammation and preventing excessive swelling.

It is primarily used during acute HAE attacks to quickly reduce swelling but can also be administered as a preventive measure for those who experience frequent or severe episodes. Given intravenously, it is often considered a first-line treatment for both acute and preventive care.

Relief from swelling typically occurs within hours, with the effects lasting for several days. Regular use can help reduce both the frequency and severity of attacks.

Ecallantide

Ecallantide works by inhibiting kallikrein, an enzyme that triggers the overproduction of bradykinin, a substance responsible for swelling in HAE patients.

It is used to treat acute hereditary angioedema attacks and is administered via subcutaneous injection. Ecallantide is generally reserved for patients who do not respond to C1 inhibitor concentrate or other treatments. It is not intended for prevention but to halt ongoing attacks.

Symptom relief usually begins within a few hours, with swelling continuing to subside throughout the day.

Icatibant

Icatibant is a bradykinin receptor antagonist that blocks the action of bradykinin, the substance responsible for swelling during HAE attacks.

It is used for acute attacks and is administered subcutaneously. Icatibant is often chosen when C1 inhibitor concentrate is unavailable or for patients who prefer self-administration. It is not used for long-term prevention.

Most patients experience symptom relief within 1 to 2 hours after injection.

Berotralstat

Berotralstat is an oral medication that inhibits kallikrein, reducing the production of bradykinin and helping to prevent HAE attacks.

It is used for long-term prevention and is taken daily. Typically prescribed for patients with frequent attacks, it helps reduce the need for injectable treatments.

Patients often notice a reduction in attack frequency and severity within a few weeks of starting berotralstat.

Danazol

Danazol is an attenuated androgen, a synthetic hormone that increases the production of C1 inhibitor, helping to prevent HAE attacks.

It is used for long-term prevention and is taken orally, typically prescribed for patients who do not respond to other preventive treatments. Due to potential side effects, it is often reserved for more severe cases.

Patients may see a reduction in attack frequency, though it may take several weeks to experience the full benefits. Long-term use requires monitoring for side effects.

Stanozolol

Stanozolol, another attenuated androgen, works similarly to danazol by increasing C1 inhibitor levels.

It is used for long-term prevention and is taken orally. Stanozolol is often prescribed for patients who do not respond to other treatments or need additional preventive measures.

Patients may notice a reduction in attack frequency after a few weeks, but regular monitoring is necessary due to potential side effects.

Tranexamic Acid

Tranexamic acid is an antifibrinolytic agent that helps prevent the breakdown of blood clots, which can reduce the frequency of HAE attacks.

It is used for long-term prevention and is taken orally, typically prescribed for patients with milder HAE or those intolerant to other treatments.

Patients may experience a gradual reduction in attack frequency, though it may take several weeks to see the full benefits.

Fresh Frozen Plasma

Fresh frozen plasma (FFP) contains C1 inhibitor and other proteins that help regulate inflammation.

FFP is used as an emergency treatment for acute HAE attacks when C1 inhibitor concentrate is unavailable. It is administered intravenously in a hospital setting.

Relief from swelling typically occurs within a few hours, but FFP is considered a last-resort option due to the risk of allergic reactions and other complications.

Attenuated Androgens

Attenuated androgens, such as danazol and stanozolol, are synthetic hormones that increase C1 inhibitor production.

These medications are used for long-term prevention and are taken orally. They are generally reserved for patients unresponsive to other treatments or those with severe HAE.

Patients can expect a reduction in attack frequency, but long-term use may require monitoring for side effects such as liver damage or hormonal imbalances.

C1 Inhibitor Replacement Therapy

C1 inhibitor replacement therapy involves regular infusions of C1 inhibitor concentrate to prevent HAE attacks.

This treatment is used for long-term prevention in patients with frequent or severe attacks. It is administered intravenously, typically every few days or weeks, depending on the patient’s needs.

Regular use of C1 inhibitor replacement therapy can significantly reduce both the frequency and severity of attacks.

Improving Hereditary Angioedema Management and Seeking Medical Help

While medications are essential for managing hereditary angioedema, lifestyle changes and home remedies can also help reduce the frequency and severity of attacks. Avoiding known triggers, such as specific foods or medications, can prevent flare-ups. Stress management techniques, like meditation or deep breathing exercises, are beneficial, as stress is a common trigger for HAE. Regular exercise, a balanced diet, and staying hydrated can improve overall health and reduce the likelihood of attacks.

Wearing medical alert identification is crucial for HAE patients, as it provides essential information to healthcare providers during emergencies. Keeping a symptom diary can help track triggers and patterns, making it easier to manage the condition. Educating family and friends about HAE ensures they are prepared to assist during an attack. Additionally, avoiding extreme temperatures and practicing relaxation techniques can minimize the risk of attacks.

Telemedicine offers a convenient way to manage hereditary angioedema, allowing patients to consult healthcare providers from the comfort of their homes. This is particularly helpful for those experiencing frequent attacks or needing regular monitoring. If you experience HAE symptoms or need assistance managing your condition, telemedicine can provide timely, effective care.

Living with Hereditary Angioedema: Tips for a Better Quality of Life

Living with hereditary angioedema can be challenging, but with the right strategies, patients can lead fulfilling lives. Staying informed about your condition and following your treatment plan is essential for managing symptoms. Regular check-ins with your healthcare provider, whether in person or via telemedicine, ensure your treatment remains effective and adjustments are made as needed.

Building a support network of family, friends, and healthcare professionals provides both emotional and practical support during difficult times. Prioritizing self-care, including stress management, regular exercise, and a healthy diet, is also important. By taking proactive steps to manage your condition, you can improve your quality of life and reduce the impact of hereditary angioedema on your daily activities.

Conclusion

Hereditary angioedema is a rare but serious condition that can cause unpredictable, potentially life-threatening swelling. Early diagnosis and treatment are crucial for managing symptoms and preventing complications. With a combination of medications, lifestyle changes, and regular monitoring, patients can effectively manage their condition and reduce the frequency of attacks.

If you or a loved one is experiencing symptoms of hereditary angioedema, seeking medical help through our telemedicine practice can provide the care and support you need. Our healthcare professionals are here to help you navigate your condition and develop a personalized treatment plan. Don’t wait—schedule a consultation today to take control of your health.

James Kingsley

Learn More